Mobile Mindfulness to Improve Psychological Distress After Critical Illness
2 other identifiers
interventional
90
1 country
2
Brief Summary
Many survivors of the intensive care unit (ICU) suffer from persistent symptoms of depression, anxiety, and post-traumatic stress disorder (PTSD). In this study, the investigators will test the impact of mindfulness to address this distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
March 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2017
CompletedResults Posted
Study results publicly available
January 10, 2018
CompletedFebruary 7, 2018
January 1, 2018
1.2 years
February 24, 2016
November 15, 2017
January 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Percent of Eligible Participants Who Provided Consent
Percent of eligible participants who provided consent. Because this includes eligible yet not-as-yet randomized participants, there are no study arm differences analyzed. This is a feasibility measure. Target is 70%.
pre-randomization
Percent of Eligible Participants Who Provide Informed Consent and Were Randomized
Percent of eligible participants who provide informed consent and were randomized. A measure of feasibility. Target is 60%.
randomization
Client Satisfaction Questionnaire (CSQ) Score
Acceptability was measured with the adapted Client Satisfaction Questionnaire (CSQ), which assesses credibility and satisfaction (range 9 \[low, a worse outcome\] to 36 \[highest, a better outcome\]). Target is mean score \>10.
1 month post-randomization
System Usability Scale (SUS)
Usability of the mobile app was assessed with open-ended participant feedback and with the 10-item System Usability Scale (SUS; 0 \[lowest\] to 100 \[highest\]). A SUS score above a 68 would be considered above average and anything below 68 is below average.
1 month post-randomization
Percent of Randomized Participants Who Drop Out of Study
A feasibility measure. Target is 20% or less.
baseline, end of study (approx. 4 months)
Percent of Participants Who Have Neither Dropped Out Nor Died Who Complete Telephone Interviews
Percent of participants who have neither dropped out nor died who complete telephone interviews. A feasibility measure. Target is 75%.
baseline, end of study (approx. 4 months)
Percent of Participants in the Self-directed MBT Group Who Complete Weekly Surveys
A feasibility measure. Target is 60%. Note that this is for completion of ALL FOUR weekly surveys.
baseline, end of study (approx. 4 months)
Percentage of Self-directed MBT Sessions Attended by Eligible Participants
A feasibility measure. Target is 50% among those who neither dropped out nor died.
baseline, end of study (approx. 4 months)
Visual Analog Satisfaction Scale
A measure of acceptability of the intervention. Target mean score is 75% or greater.
after intervention completion, up to 8 weeks post-randomization
Number of Participant Clicks on Study Website
A usability measure obtained using Google Analytics.
baseline, end of study (approx. 4 months)
Secondary Outcomes (6)
Change in Psychological Distress Symptoms as Measured by the Patient Health Questionnaire (PHQ) Scale
Between randomization and 3 months post-randomization
Change in Distress Associated With Physical Symptoms
Between randomization and 3 months post-randomization
Change in Mindfulness Skills
Between randomization and 3 months post-randomization
Change in Psychological Distress Symptoms as Measured by the GAD-7
Between randomization and 3 months post-randomization
Change in Psychological Distress Symptoms as Measured by the PTSS
Between randomization and 3 months post-randomization
- +1 more secondary outcomes
Other Outcomes (1)
Usability Themes Developed From Semi-structured Participant Interviews
end of study
Study Arms (3)
Education group
ACTIVE COMPARATORA care condition in which an educational program relevant to critical illness is presented in a web-based format similar to the other arms. Telephone calls will be used to answer questions and assist with web content.
Standard mindfulness
EXPERIMENTALReceives audiovisual mindfulness content via internet plus 1 call per week from a trained mindfulness expert.
Mobile mindfulness
EXPERIMENTALReceives audiovisual mindfulness content via web-app. Will receive at least 1 call from a trained mindfulness expert, though up to 4 total calls based on symptoms / request.
Interventions
Receives audiovisual mindfulness content via internet plus call depending on symptoms or request.
Receives weekly calls from mindfulness expert for 4 weeks.
Receives web-based content about critical illness topics. Also receives two calls from study team to describe materials and answer questions about materials.
Eligibility Criteria
You may qualify if:
- age ≥18 years
- acute cardiorespiratory failure managed in an intensive care unit
- reside at home before hospital admission (i.e., not in a facility)
- Respiratory failure, ≥1 of these:
- mechanical ventilation via endotracheal tube for ≥ 12 hours
- non-invasive ventilation (CPAP, BiPAP) for \> 4 hours in a 24 hour period provided for acute respiratory failure in an ICU (not for obstructive sleep apnea or other stable use)
- high flow nasal cannula or face mask O2 with FiO2 ≥ 0.5 for ≥4 hours
- Cardiac / circulatory failure, ≥1 of these:
- use of vasopressors for shock of any etiology for \> 1 hour
- use of inotropes for shock of any etiology for \> 1 hour
- use of aortic balloon pump for cardiogenic shock
You may not qualify if:
- pre-existing significant cognitive impairment (e.g., dementia)
- treated for severe or unstable mental illness within 6 months preceding current admission (e.g., depression with psychosis, suicidality, schizophrenia as per medical record)
- hospital inpatient within 3 months before current admission
- active substance abuse at the time of admission
- lack of decisional capacity \[\*'Decisional capacity' is defined as the ability to participate in effective decision making and provide informed consent. That is, in the judgment of the examiner, the patient, after reading the IRB approved patient consent document (or having it read to them) can (a) generally understand the terms of participation in the study: the purpose of the study, what will be required of study participants; the potential risks, benefits and alternatives of study participation; pros \& cons of study involvement and (b) can communicate a choice in his/her own words (or write on a communication board)\]
- current significant cognitive impairment (≥3 errors on the Callahan cognitive status screen; see below)
- need for a translator because of poor English fluency \[many study instruments are not validated in other languages\]
- expected survival \<6 months per attending physician
- ICU length of stay \>30 days
- lack of either:
- reliable or sufficient smartphone with cellular data plan or
- reliable computer online access plus telephone access
- unable to complete study procedures as determined by study staff
- discharge to a location other than a home setting
- complex medical care expected soon after discharge (e.g., multiple planned surgeries, transplantation evaluation (including outpatient daily cardiopulmonary rehabilitation), extensive travel needs for hemodialysis, disruptive chemotherapy or XRT regimen, etc)
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of Washingtoncollaborator
- University of Pennsylvaniacollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
Study Sites (2)
Duke University
Durham, North Carolina, 27710, United States
University of Washington
Seattle, Washington, 98195, United States
Related Publications (2)
Cox CE, Porter LS, Buck PJ, Hoffa M, Jones D, Walton B, Hough CL, Greeson JM. Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc. 2014 Feb;11(2):173-81. doi: 10.1513/AnnalsATS.201308-283OC.
PMID: 24303911BACKGROUNDCox CE, Hough CL, Jones DM, Ungar A, Reagan W, Key MD, Gremore T, Olsen MK, Sanders L, Greeson JM, Porter LS. Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial. Thorax. 2019 Jan;74(1):33-42. doi: 10.1136/thoraxjnl-2017-211264. Epub 2018 May 23.
PMID: 29793970DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Christopher Cox
- Organization
- Duke University Health System
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher E Cox, MD
Duke University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2016
First Posted
March 8, 2016
Study Start
March 1, 2016
Primary Completion
May 1, 2017
Study Completion
July 5, 2017
Last Updated
February 7, 2018
Results First Posted
January 10, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share